169 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
platforms which may demonstrate greater market acceptance or superiority; Ligand is currently dependent on a single source sole supplier for Captisol … and failures by such supplier may result in delays or inability to meet the Captisol demands of its partners; Ligand’s partners may change
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
market acceptance or superiority; Ligand is currently dependent on a single source sole supplier for Captisol and failures by such supplier may result
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
on a single source sole supplier for Captisol and failures by such supplier may result in delays or inability to meet the Captisol demands of its partners
8-K
EX-99.1
6dhe816p 32p
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
f84cq tjabc2aro
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
mu26 it3g1um
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
owyz jgnjhn
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
sx7pb n3hm9dwev946nd
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
jf7 c8dvv
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
23mc90qamhaa lcb66r
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
g1lt zfnq8orl
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
fd18xnxss
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
jxnmhlcxorbi8
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
sy5pd4uqvtyvzik76
24 Mar 22
Entry into a Material Definitive Agreement
9:08am